WallStreetZenWallStreetZen

NASDAQ: LEXX
Lexaria Bioscience Corp Stock

$2.92-0.53 (-15.36%)
Updated Mar 1, 2024
LEXX Price
$2.92
Fair Value Price
$3.41
Market Cap
$30.47M
52 Week Low
$0.65
52 Week High
$3.60
P/E
-3.48x
P/B
8.14x
P/S
49.19x
PEG
N/A
Dividend Yield
N/A
Revenue
$276.01k
Earnings
-$6.11M
Gross Margin
92.6%
Operating Margin
-2,215.46%
Profit Margin
-2,207.9%
Debt to Equity
0.07
Operating Cash Flow
-$6M
Beta
0.67
Next Earnings
Apr 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

LEXX Overview

Lexaria Bioscience Corporation is a biotech company developing a drug delivery technology, DehydraTECH, that improves the way active pharmaceutical ingredients enter the bloodstream. Dehydra being evaluated for orally administered anti-viral drugs and non-steroidal anti-inflammatory drugs. Lexaria Bioscience was incorporated in 2004 and is headquartered in Kelowna, British Columbia, Canada.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LEXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LEXX ($2.92) is undervalued by 14.4% relative to our estimate of its Fair Value price of $3.41 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
LEXX ($2.92) is not significantly undervalued (14.4%) relative to our estimate of its Fair Value price of $3.41 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LEXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LEXX due diligence checks available for Premium users.

Be the first to know about important LEXX news, forecast changes, insider trades & much more!

LEXX News

Valuation

LEXX fair value

Fair Value of LEXX stock based on Discounted Cash Flow (DCF)
Price
$2.92
Fair Value
$3.41
Undervalued by
14.40%
LEXX ($2.92) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LEXX ($2.92) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LEXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

LEXX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.48x
Industry
15.19x
Market
36.17x

LEXX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.14x
Industry
6.18x
LEXX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LEXX's financial health

Profit margin

Revenue
$151.3k
Net Income
-$1.2M
Profit Margin
-783.4%
LEXX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LEXX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.6M
Liabilities
$254.0k
Debt to equity
0.07
LEXX's short-term assets ($2.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LEXX's short-term assets ($2.69M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LEXX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
LEXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$40.0k
Financing
$1.8M
LEXX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LEXX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
LEXX$30.47M-15.36%-3.48x8.14x
NRBO$30.27M+7.77%0.16x1.40x
RGLS$30.13M+1.36%-0.94x1.07x
VYNE$30.99M-0.45%-0.22x2.69x
APRE$29.89M-5.44%0.65x1.47x

Lexaria Bioscience Stock FAQ

What is Lexaria Bioscience's quote symbol?

(NASDAQ: LEXX) Lexaria Bioscience trades on the NASDAQ under the ticker symbol LEXX. Lexaria Bioscience stock quotes can also be displayed as NASDAQ: LEXX.

If you're new to stock investing, here's how to buy Lexaria Bioscience stock.

What is the 52 week high and low for Lexaria Bioscience (NASDAQ: LEXX)?

(NASDAQ: LEXX) Lexaria Bioscience's 52-week high was $3.60, and its 52-week low was $0.65. It is currently -18.78% from its 52-week high and 349.92% from its 52-week low.

How much is Lexaria Bioscience stock worth today?

(NASDAQ: LEXX) Lexaria Bioscience currently has 10,435,441 outstanding shares. With Lexaria Bioscience stock trading at $2.92 per share, the total value of Lexaria Bioscience stock (market capitalization) is $30.47M.

Lexaria Bioscience stock was originally listed at a price of $98.19 in Feb 12, 2007. If you had invested in Lexaria Bioscience stock at $98.19, your return over the last 17 years would have been -97.03%, for an annualized return of -18.68% (not including any dividends or dividend reinvestments).

How much is Lexaria Bioscience's stock price per share?

(NASDAQ: LEXX) Lexaria Bioscience stock price per share is $2.92 today (as of Mar 1, 2024).

What is Lexaria Bioscience's Market Cap?

(NASDAQ: LEXX) Lexaria Bioscience's market cap is $30.47M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lexaria Bioscience's market cap is calculated by multiplying LEXX's current stock price of $2.92 by LEXX's total outstanding shares of 10,435,441.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.